Faculty profile

Volker Gerdts

ResearcherUniversity of Saskatchewan

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Saskatchewan directory, so their courses may be missing. Find their university profile.

Volker Gerdts

Researcher

Health Sciences

University of Saskatchewan

Saskatoon, Saskatchewan, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
26 publications in the last five years, latest in 2026.
Senior (last) author on 3 recent papers, a sign of leading a research group.
Principal investigator on 7 research grants (5 NSERC, 2 CIHR), most recently in 2020.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

115

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Influenza Lipids Nanoparticles Pertussis Polymers Vaccine Vaccine Adjuvants Virus

Latest papers

Initiation of a coronavirus vaccine library.
Vaccine · 2026
Safety and immunogenicity of a booster dose of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in previously vaccinated healthy adults; a randomized controlled multicentre trial.
Human vaccines & immunotherapeutics · 2026
A call to action to address critical flaws and bias in laboratory animal experiments and preclinical research.
Scientific reports · 2025

All 115 publications

Latest funding

Novel Approaches to Generating Transgenic Pigs Suitable for Organ Xenotransplantation
SSHRC · 2023 · Co-investigator
$250,000
COVID-19 Variant Supplement - Vaccine efficacy in nonhuman primates against SARS-CoV-2: protection, cross-protection and immune enhancement
CIHR · 2021 · Co-investigator
$50,000
Animal models for SARS-CoV-2: vaccines and immune enhancement
CIHR · 2020 · Co-investigator
$999,793

All 18 grants and awards

115 publications.

Initiation of a coronavirus vaccine library.

Kovacs D, Brar G, Anthony SJ, Wang LF, Holmes EC, Saif LJ, Gerdts V, Poon L, Perlman S, Vandeputte J, Drosten C, Wells HL, Castillo-Olivares J, Brasel T, Endy T, Steff AM, Thiry G, Cohen N

Vaccine2026

DOI: 10.1016/j.vaccine.2025.128140 PMID: 41422789

Safety and immunogenicity of a booster dose of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in previously vaccinated healthy adults; a randomized controlled multicentre trial.

Hamonic G, Arora S, Garg R, Scruten E, Buchanan R, Saundh SL, Collin N, Sanche S, Vale N, Salter T, Halperin SA, Langley JM, Gerdts V, Racine T

Human vaccines & immunotherapeutics2026

DOI: 10.1080/21645515.2026.2683765 PMID: 42268674

A call to action to address critical flaws and bias in laboratory animal experiments and preclinical research.

Townsend HGG, Osterrieder K, Jelinski MD, Morck DW, Waldner CL, Cox WR, Gerdts V, Potter AA, Babiuk LA, Cross JC

Scientific reports2025

DOI: 10.1038/s41598-025-15935-4 PMID: 40841741

Dairy cows develop protective immunity against reinfection with bovine H5N1 influenza virus.

Facciuolo A, Aubrey L, Barron-Castillo U, Berube N, Norleen C, McCreary S, Huang Y, Pessoa N, Jacome LM, Mubareka S, McGeer A, Berhane Y, Gerdts V, Van Kessel A, Warner B, Zhou Y

Nature microbiology2025

DOI: 10.1038/s41564-025-01998-6 PMID: 40247094

Meeting report: CEPI workshop on Rift Valley fever epidemiology and modeling to inform human vaccine development, Nairobi, 4-5 June 2024.

Gharpure R, Vegvari C, Abdissa A, Alimi Y, Anyamba A, Auerbach J, Bett B, Bird BH, Bob NS, Breugelmans JG, Clark J, Cleaveland S, Cramer J, Dawa J, Fay PC, Formenty P, Gerdts V, Gerken KN, Gitonga J, Groschup M, Heighway J, Johnson SAM, Juma J, Kading RC, Kamau M, Kerama S, Lubisi BA, Lutwama J, Luyimbazi D, Marami D, Moore SM, Muturi M, Mwangoka G, Ndiu A, Njenga MK, Njouom R, Nyakarahuka L, Nzietchueng S, Oloo P, Otiende M, Oyola S, Paganini LS, Pandit PS, Punt C, Samy AM, Situma S, Sneddon H, Ten Bosch QA, Tezcan-Ulger S, Thompson PN, Tildesley M, Tinto B, Vesga JF, Wichgers Schreur PP, Hart P

Vaccine2025

DOI: 10.1016/j.vaccine.2025.126860 PMID: 40101455

Immunogenicity of virus-like particle vaccine candidates against SARS-CoV-2 infection.

Nguyen HT, Garg R, Kroeker A, Gerdts V, Falzarano D, Liu Q

Access microbiology2025

DOI: 10.1099/acmi.0.000925.v3 PMID: 39967742

Design-of-experiments based development and in vitro evaluation of a cationic lipid-based triple adjuvanted subunit pertussis vaccine.

Mandava TT, Gerdts V, Ejlali M, Wasan EK

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V2025

DOI: 10.1016/j.ejpb.2025.114890 PMID: 41047086

Safety and immunogenicity of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in healthy adults; a randomized controlled first-in-human dose-escalation trial.

Hamonic G, Pastural E, Arora S, Lew J, Cai Y, Scruten E, Buchanan R, ElSherif M, Ye L, Courant T, Ventura RA, Collin N, Daugan M, Gagnon L, Hodgson P, van Drunen Little-van den Hurk S, Falzarano D, Sanche S, Halperin SA, Langley JM, Gerdts V, Racine T

Vaccine2025

DOI: 10.1016/j.vaccine.2025.127748 PMID: 40957309

Efficacy of a stable broadly protective subunit vaccine platform against SARS-CoV-2 variants of concern.

Garg R, Liu Q, Van Kessel J, Asavajaru A, Uhlemann EM, Joessel M, Hamonic G, Khatooni Z, Kroeker A, Lew J, Scruten E, Pennington P, Deck W, Prysliak T, Nickol M, Apel F, Courant T, Kelvin AA, Van Kessel A, Collin N, Gerdts V, Köster W, Falzarano D, Racine T, Banerjee A

Vaccine2024

DOI: 10.1016/j.vaccine.2024.05.028 PMID: 38769033

Construction and immunogenicity of SARS-CoV-2 virus-like particle expressed by recombinant baculovirus BacMam.

Nguyen HT, Falzarano D, Gerdts V, Liu Q

Microbiology spectrum2024

DOI: 10.1128/spectrum.00959-24 PMID: 38916311

Novel Approaches to Generating Transgenic Pigs Suitable for Organ Xenotransplantation

Co-investigatorSSHRC2023New Frontiers in Research Fund - Exploration

Principal investigators: Honaramooz, Ali

Keywords: Genetic modification of pigs; Xenotransplantation; Animal transgenesis; Graft rejection; Applied immunology; Germ cell transplantation; Histocompatiblity; Organ and tissue transplants

$250,000

COVID-19 Variant Supplement - Vaccine efficacy in nonhuman primates against SARS-CoV-2: protection, cross-protection and immune enhancement

Co-investigatorCIHR2021Operating Grant: SARS-CoV-2 variants supplement stream 1

Principal investigators: Falzarano, Darryl

Keywords: Animal Model; Immune Enhancement; Immunogenicity; Nonhuman Primate; Pre-Clinical; Protection; Sars-Cov-2; Vaccine; Vaccine Safety

$50,000

Animal models for SARS-CoV-2: vaccines and immune enhancement

Co-investigatorCIHR2020Operating Grant: COVID-19 - Vaccines

Principal investigators: Falzarano, Darryl

Keywords: Animal Model; Coronavirus; Covid-19; Immune Enhancement; One Health; Pre-Existing Immunity; Sars-Cov; Sars-Cov-2; Transmission; Vaccine

$999,793

Vaccine efficacy in nonhuman primates against SARS-CoV-2: protection, cross-protection and immune enhancement

Co-investigatorCIHR2020Operating Grant: COVID-19 Rapid Research Funding Opportunity - Vaccines

Principal investigators: Falzarano, Darryl

Keywords: Animal Model; Immune Enhancement; Immunogenicity; Nonhuman Primate; Pre-Clinical; Protection; Sars-Cov-2; Vaccine; Vaccine Safety

$1,459,325

Sex as a Biological Variable Supplement - Animal models for SARS-CoV-2: vaccines and immune enhancement

Co-investigatorCIHR2020Op Grant: Sex as a Biological Variable Supplement: COVID-19 Rapid Research FO

Principal investigators: Falzarano, Darryl

Keywords: Animal Model; Coronavirus.; Covid-19; Immune Enhancement; One Health; Pre-Existing Immunity; Sars-Cov; Sars-Cov-2; Transmission; Vaccine

$50,000

Intranasal Vaccines for Pertussis and Influenza Using Novel Formulations of a Triple Adjuvant

Principal investigatorCIHR2020Project Grant

Principal investigators: Wasan, Ellen K; Gerdts, Volker; Zhou, Yan

Keywords: Influenza; Lipids; Nanoparticles; Pertussis; Polymers; Vaccine; Vaccine Adjuvants; Virus

$745,876

Understanding the role of porcine dendritic cells during acute and chronic viral infections

Principal investigatorNSERC2015Discovery Grants Program - Individual

Principal investigators: Gerdts, Volker

$190,000

Evaluating efficacy of phage-based treatment for neonatal scours in piglets

Principal investigatorNSERC2014Engage Grants Program

Principal investigators: Gerdts, Volker

$25,000

Developing novel vaccines for respiratory syncytial virus and parainfluenza virus type 3

Co-investigatorCIHR2013Operating Grant: Canada-China Human Vaccines - Full Application

Principal investigators: Potter, Andrew

Keywords: Novel

$485,283

Harvesting the anti-inflammatory properties of nutritional portfolios for intestinal health.

Co-investigatorCIHR2012Operating Grant: Programmatic Grants in Food and Health - LOI

Principal investigators: Jones, Jennifer L; Reaney, Martin J

Keywords: Cyclopeptides; Fiber; Flax; Inflammation; Intestinal Health; Lignans; Nutrition

$10,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Volker Gerdts

Research

Latest papers

Latest funding

Initiation of a coronavirus vaccine library.

Safety and immunogenicity of a booster dose of COVAC-2, a Sepivac SWE&#x2122; adjuvanted SARS-CoV-2 recombinant protein vaccine in previously vaccinated healthy adults; a randomized controlled multicentre trial.

A call to action to address critical flaws and bias in laboratory animal experiments and preclinical research.

Dairy cows develop protective immunity against reinfection with bovine H5N1 influenza virus.

Meeting report: CEPI workshop on Rift Valley fever epidemiology and modeling to inform human vaccine development, Nairobi, 4-5 June 2024.

Immunogenicity of virus-like particle vaccine candidates against SARS-CoV-2 infection.

Design-of-experiments based development and in vitro evaluation of a cationic lipid-based triple adjuvanted subunit pertussis vaccine.

Safety and immunogenicity of COVAC-2, a Sepivac SWE&#x2122; adjuvanted SARS-CoV-2 recombinant protein vaccine in healthy adults; a randomized controlled first-in-human dose-escalation trial.

Efficacy of a stable broadly protective subunit vaccine platform against SARS-CoV-2 variants of concern.

Construction and immunogenicity of SARS-CoV-2 virus-like particle expressed by recombinant baculovirus BacMam.

Novel Approaches to Generating Transgenic Pigs Suitable for Organ Xenotransplantation

COVID-19 Variant Supplement - Vaccine efficacy in nonhuman primates against SARS-CoV-2: protection, cross-protection and immune enhancement

Animal models for SARS-CoV-2: vaccines and immune enhancement

Vaccine efficacy in nonhuman primates against SARS-CoV-2: protection, cross-protection and immune enhancement

Sex as a Biological Variable Supplement - Animal models for SARS-CoV-2: vaccines and immune enhancement

Intranasal Vaccines for Pertussis and Influenza Using Novel Formulations of a Triple Adjuvant

Understanding the role of porcine dendritic cells during acute and chronic viral infections

Evaluating efficacy of phage-based treatment for neonatal scours in piglets

Developing novel vaccines for respiratory syncytial virus and parainfluenza virus type 3

Harvesting the anti-inflammatory properties of nutritional portfolios for intestinal health.

Frequent collaborators

Andrew Potter

Darryl Falzarano

Uladzimir Karniychuk

David Safronetz

Sylvia Van Drunen Littel-van den Hurk

Hugh Townsend

Yan Zhou

Shokrollah Elahi

Christopher Richardson

Brian Cox

Arinjay Banerjee

Steven Machtaler

Samira Mubareka

Yohannes Berhane

Bryce Warner

Lakshmi Krishnan

Robert Kozak

Neeraj Dhar

Shima Shahbaz

Mariela Segura

Cordell Neudorf

Gary Kobinger

Sharon Walmsley

Punam Pahwa

Tony Mazzulli

Anne-Claude Gingras

Finlay Maguire

Marcelo Gottschalk

Mariela Segura

Paul Hodgson

Safety and immunogenicity of a booster dose of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in previously vaccinated healthy adults; a randomized controlled multicentre trial.

Safety and immunogenicity of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in healthy adults; a randomized controlled first-in-human dose-escalation trial.